lifibrol has been researched along with Hypercholesterolemia in 5 studies
*Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthold, HK; Gouni-Berthold, I; Sudhop, T; von Bergmann, K | 1 |
| Francom, SF; Hughes, GS; Jungbluth, GL; Locker, PK | 1 |
| Augustin, J; Elsässer, R; Gertz, B; Heil, M; Schmidt, C; Schwandt, P; Seibel, K | 1 |
| Friedrich, I; Klima, B; Köster, W; März, W; Nuber, C; Sattler, A; Schäfer, JR; Steinmetz, A; Wieland, H; Winkler, K | 1 |
| Adams-Huet, B; Blumenschein, S; Carter, NB; Grundy, SM; Laeis, P; Lindenthal, B; Lutjohann, D; Simatupang, A; Vega, GL; von Bergmann, J; von Bergmann, K | 1 |
5 trial(s) available for lifibrol and Hypercholesterolemia
| Article | Year |
|---|---|
Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
Topics: Adult; Anticholesteremic Agents; Apolipoprotein B-100; Butanols; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Double-Blind Method; Humans; Hydroxybenzoates; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lipoproteins, LDL; Male; Pravastatin; Triglycerides; Young Adult | 2010 |
Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group.
Topics: Adolescent; Adult; Aged; Apolipoproteins; Bile Acids and Salts; Butanols; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroxybenzoates; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Sex Factors; Sterols | 1995 |
Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia.
Topics: Anticholesteremic Agents; Butanols; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydroxybenzoates; Hypercholesterolemia; Lipids; Male; Middle Aged; Triglycerides | 1994 |
Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins B; Butanols; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxybenzoates; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome | 1999 |
Effect of lifibrol on the metabolism of low density lipoproteins and cholesterol.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Butanols; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxybenzoates; Hypercholesterolemia; Hypolipidemic Agents; Male; Mevalonic Acid; Middle Aged; Simvastatin; Single-Blind Method; Triglycerides | 1999 |